Seroprevalence and Risk Factors for Hepatitis B and C infection among pregnant women attending a government hospital in Delhi
DOI:
https://doi.org/10.56450/JEFI.2025.v3i01.007Keywords:
Hepatitis B, Hepatitis C, Seroprevalence, Risk FactorsAbstract
Background: Hepatitis B virus (HBV) and Hepatitis C virus (HCV) infection during pregnancy is associated with perinatal transmission contributing to the pool of HBV and HCV infection. Pregnant women with chronic hepatitis B and positive Hepatitis B virus E antigen (HBeAg) have a 90% likelihood of transmitting the hepatitis B virus to their newborns. Vertical (mother-to-child) transmission is the leading cause of HCV infection in children. Though there is much data on the overall prevalence of HBV and HCV infection among the general population, only a few studies are focusing on the seroprevalence of HBV and HCV among pregnant women. Methodology: A cross-sectional, descriptive study conducted in Delhi. A total of 422 pregnant women attending the antenatal clinic for the first time were interviewed for risk factors for transmission and then tested for HBsAg and anti-HCV using rapid diagnostic test kit. Results: The seroprevalence for HBsAg and anti-HCV among the participants was 2.1% and 0.2%, respectively. Risk factor assessment revealed a significant association with the history of blood or blood product transfusion. Conclusion: Prevalence rates for HBsAg are higher than those reported in some previous studies and the national average. More in-depth research studies are needed to identify potential risk factors significantly contributing to the disease burden for the targeted approach to eliminate infection.
Downloads
References
1. Hepatitis [Internet]. Available from: https://www.who.int/health-topics/hepatitis#tab=tab_1 (Accessed on 25-03-2025)
2. Global Hepatitis Report 2024. Action for Access in Low- and Middle -Income Countries. World Health Organization; 2024.
3. Mehta P, Reddivari AKR. Hepatitis. StatPearls; Available from: https://www.ncbi.nlm.nih.gov/books/NBK554549/ (Accessed on 25-03-2025)
4. Asafo-Agyei KO, Samant H. Pregnancy and Viral Hepatitis. StatPearls [Internet]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK556026/ (Accessed on 25-03-2025)
5. Premkumar M, Kumar Chawla Y. Chronic Hepatitis B: Challenges and Successes in India. Clin Liver Dis (Hoboken). 2021;18(3):111-16.
6. Seroprevalence of Hepatitis B and C Factsheet. Available from: https://nvhcp.mohfw.gov.in/common_libs/Approved%20factsheet_4_10_2021.pdf (Accessed on 25-03-2025)
7. Kumar A, Gupta R. Prevalence & risk factors for hepatitis C virus among pregnant women [Internet]. The Indian Journal of Medical Research. 2007;126(3)211-5
8. Gedefaw G, Waltengus F, Akililu A, Gelaye K. Risk factors associated with hepatitis B virus infection among pregnant women attending antenatal clinic at Felegehiwot referral hospital, Northwest Ethiopia, 2018: An institution based cross sectional study. BMC Res Notes. 2019 Aug 15;12(1):509.
9. Israr M, Ali F, Nawaz A, Idrees M, Khattak A, Rehman SU, et al. Seroepidemiology and associated risk factors of hepatitis B and C virus infections among pregnant women attending maternity wards at two hospitals in Swabi, Khyber Pakhtunkhwa, Pakistan. PLoS One. 2021;16(8):e0255189.
10. Mittal G, Gupta P, Gupta R, Ahuja V, Mittal M, Dhar M. Seroprevalence and risk factors of hepatitis B and hepatitis C virus infections in uttarakhand, India. J Clin Exp Hepatol [Internet]. 2013;3(4):296–300.
11. Upreti P, Singh RK, Arya V. Burden of HCV infection among pregnant women with assessment of risk factors and pregnancy outcome in HCV infected: A hospital based study from Uttarakhand. 2017;05(1)17250-17256.
12. Rajendiran S, Gopalan U, Jayakumar K. Seroprevalence of Hepatitis B infection among pregnant women in South India. Int J Reprod Contracept Obstet Gynecol. 2016;6(1):249.
13. Pandey S, Lohani P, Roy R, Bhar D, Ranjan A, Kumar P, et al. Prevalence and knowledge of hepatitis B infection in pregnant women in a primary health center of Patna district, Bihar. J Family Med Prim Care. 2021;10(10):3675.
14. Sibia P, Mohi MK, Kumar A. Seroprevalence of Hepatitis B Infection among Pregnant Women in One of the Institute of Northern India. J Clin Diagn Res;10(8):QC08.
15. Dwivedi M, Misra SP, Misra V, Pandey A, Pant S, Singh R, et al. Seroprevalence of hepatitis B infection during pregnancy and risk of perinatal transmission. Indian J Gastroenterol;30(2):66–71.
16. Satsangi S, Dhiman RK. Combating the wrath of viral hepatitis in India. Indian J Med Res. 2016;144(1):1.
17. Goyal LD, Kaur S, Jindal N, Kaur H. HCV and pregnancy: prevalence, risk factors, and pregnancy outcome in north Indian population: a case-control study. J Obstet Gynaecol India. 2014;64(5):332–6.
18. Jahan N, Chaudhary N, Nigar A, Ahmad S, Khatoon R, Kumar A. Prevalence of hepatitis C among pregnant females attending antenatal clinic at a tertiary care hospital in Lucknow, Uttar Pradesh, India. International Journal of Advances in Medicine. 2020;7(2):314.
19. Giri S, Sahoo S, Angadi S, Afzalpurkar S, Sundaram S, Bhrugumalla S. Seroprevalence of Hepatitis B Virus Among Pregnant Women in India: A Systematic Review and Meta-Analysis. J Clin Exp Hepatol. 2022;12(6):1408–19.
20. Ugbebor O, Aigbirior M, Osazuwa F, Enabudoso E, Zabayo O. The prevalence of hepatitis B and C viral infections among pregnant women. N Am J Med Sci. 2011;3(5):238–41.
